Roche Presents Lab Solution at European Conference
Roche Considers Sale of Blood Glucose Meter Unit -Reuters
Roche's Kadcyla Breast Cancer Drug Approved For Swiss Use
Correction to FDA Medication Errors Warning Story
FDA Warns Of Potential For Medication Errors With Two Breast Cancer Drugs
Roche Holding AG Q2 2011 Earnings Conference Call.
Ladies and gentlemen, good morning or good afternoon, and welcome to the Roche Third Quarter 2012 Conference Call. I'm Zoya, the conference call operator. I would like to remind you that all participants will be in listen-only mode and the conference is being recorded. After the presentation there ...
Ladies and gentlemen, good morning or good afternoon. Welcome to the Roche's Fourth Quarter 2012 Conference Call. I'm Myra, the Chorus Call Operator. I would like to remind that all participants will be in listen-only mode and the conference is being recorded. After the presentation there will be a ...
Good morning or good afternoon, depending where we are attending from. I am Myra, the Chorus Call operator for this conference. Welcome to the Roche's Third Quarter 2011 Conference Call. Please note that for the duration of the presentation all participants would be in listen-only mode. The ...
Good afternoon, ladies and gentlemen, 2011 has been a good year for Roche. We achieved all our financial goals and very importantly we made significant progress in our late-stage pipeline.